1GXC
FHA domain from human Chk2 kinase in complex with a synthetic phosphopeptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE BM14 |
Synchrotron site | ESRF |
Beamline | BM14 |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | MARRESEARCH |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 79.824, 82.884, 129.857 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 15.000 - 2.700 |
R-factor | 0.245 * |
Rwork | 0.231 |
R-free | 0.29400 * |
Structure solution method | MAD |
RMSD bond length | 0.007 * |
RMSD bond angle | 1.200 * |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Refinement software | REFMAC (5.0) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 15.000 * | 2.800 |
High resolution limit [Å] | 2.700 | 2.700 |
Rmerge | 0.039 | 0.380 |
Number of reflections | 24148 | |
<I/σ(I)> | 20.1 | |
Completeness [%] | 97.3 | 87 |
Redundancy | 3.5 * |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | Vapor diffusion * | 8 * | 18 * | pH 6.50 |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | drop | protein | 0.2 (mM) | |
2 | 1 | drop | Tris-HCl | 20 (mM) | pH8.0 |
3 | 1 | reservoir | PEG20000 | 12 (%) | |
4 | 1 | reservoir | MES | 0.1 (M) | pH6.5 |